Compounded semaglutide
Sold by Mint Med · every compounded semaglutide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
Recorded initial charges
First month
$106
first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.
| Medication · Month-to-month, lifetime price, all doses included · recorded initial monthly payment | $106 |
|---|
Added from the figures recorded below.
Price
| Term | Published rate | Charged today |
|---|---|---|
| Month-to-month, lifetime price, all doses included “$106 Monthly Compounded Semaglutide – Lifetime Price (All Doses Included)” | Per month$106 | Charged today$106 |
| Separate/older product listing: month-to-month (conflicts with the $106/mo listing above for the same drug) “Compounded Semaglutide $246/mo” | Per month$246 | Charged today$246 |
| 3 months prepaid, lifetime price, all doses included “$96/mo | Lifetime Price (All Doses Included) 3 Months Prepaid Compounded Semaglutide” | $96Published figure | Charged todayNot verified |
| 12 months prepaid, lifetime price, all doses included “$86/mo | Lifetime Price (All Doses Included) 12 Months Prepaid Compounded Semaglutide” | $86Published figure | Charged todayNot verified |
Price sources
- Month-to-month, lifetime price, all doses included · mintmed.com — read September 2026
- Separate/older product listing: month-to-month (conflicts with the $106/mo listing above for the same drug) · mintmed.com — read September 2026
- 3 months prepaid, lifetime price, all doses included · mintmed.com — read September 2026
- 12 months prepaid, lifetime price, all doses included · mintmed.com — read September 2026
We earn nothing from this link. It opens Mint Med's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| States | 36 states: Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming |
|---|---|
| Prescriber | Both |
| Cancellation | Cancellation requests must be submitted at least 48 business hours before your next scheduled order processing date. Cancellations received within 48 business hours of the order processing date cannot be processed. |
Not yet checked: pharmacy, membership and consult fee.
Recorded from mintmed.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2026 — Mint Med's own product pages contradict each other on price for the identical drug: the current collection listing prices compounded semaglutide at $106/mo (down to $86/mo on 12-month prepay) and compounded tirzepatide at $145/mo (down to $125/mo on 12-month prepay), but an older/parallel product page (compounded-semaglutide-month-to-month) prices the same compounded semaglutide at $246/mo, another (compounded-semaglutide-1) shows a $133/mo-then-$246/mo starter pack, and the how-it-works promo tile prices compounded tirzepatide at $299 (regular $499) instead of $145. Also a state-count mismatch: the homepage prose says 'Mint Med currently provides services in 35 U.S. states' but the state abbreviation list on the same page enumerates 36 distinct states.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.